Biovista has entered into a pilot research collaboration agreement with Pfizer to identify new indications for a number of Pfizer’s undisclosed development candidates.

Using their Clinical Outcome Search Space technology, Biovista will collaborate with Pfizer’s Indications Discovery Unit to identify up to three novel indications for each of the Pfizer candidates.

The terms of the agreement include an upfront payment and success-based milestones.